YCBD · XBRL financial data
cbdMD financial statements, every quarter
The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (YCBD's year ends in late September)
| In thousands of dollars | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5,711* | 5,375 | 4,377 | 5,174 | 4,556* | 5,113 | 4,749 | 4,607 | 4,721* | 5,017 | 5,640 | 5,554 |
| Cost of revenue | 2,162* | 1,818 | 1,796 | 1,770 | 2,103* | 1,713 | 1,790 | 1,776 | 1,944* | 2,016 | 2,383 | 2,516 |
| Gross profit | 3,549* | 3,557 | 2,581 | 3,404 | 2,454* | 3,401 | 2,959 | 2,831 | 2,777* | 3,001 | 3,257 | 3,038 |
| Operating income (loss) | (15,217)* | (1,066) | (1,551) | (382) | (317)* | (86) | (486) | (905) | (686)* | (286) | (801) | (1,130) |
| Other income (expense) | (59)* | — | 0 | 0 | — | — | — | — | — | — | — | — |
| Income tax expense (benefit) | 0* | 0 | — | — | year only | — | — | — | year only | — | — | — |
| Net income (loss) | (15,875) | (997) | (3,011) | 460 | (153) | 15 | (481) | (895) | (680)* | (283) | (798) | (1,127) |
| Earnings per share, basic USD per share | — | (0.67) | (1.35) | (0.15) | — | (0.22) | (1.90) | (0.21) | — | (0.04) | (0.08) | (0.11) |
| Earnings per share, diluted USD per share | — | — | (1.35) | (0.15) | — | — | — | — | — | — | — | — |
| Weighted average shares, basic thousands of shares | — | 2,961 | 2,961 | 3,593 | — | 4,552 | 778 | 5,783 | 4,925* | 9,004 | 10,444 | 10,617 |
| Weighted average shares, diluted thousands of shares | — | — | 2,961 | — | — | — | — | — | — | — | — | — |
Balance sheet
CSVFiscal quarters (YCBD's year ends in late September)
Cash flows
CSVFiscal quarters (YCBD's year ends in late September)
| In thousands of dollars | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | (15,875) | (997) | (3,011) | 460 | (153) | 15 | (481) | (895) | (680)* | (283) | (798) | (1,127) |
| Net cash from operating activities | (264)* | (106) | (704)* | 290* | 167* | (318) | (189)* | (704)* | (241)* | (812) | (723)* | (442)* |
| Purchases of property and equipment | 120* | 185 | (5)* | 0* | 10* | 164 | 16* | 1* | 3* | 165 | 6* | 18* |
| Net cash from investing activities | (120)* | (185) | 5* | 0* | (110)* | (164) | (16)* | (1)* | (3)* | (165) | 51* | (18)* |
| Proceeds from issuing common stock | 4* | — | — | 0* | 0* | — | — | 0* | 0* | — | — | — |
| Dividends paid | — | 1,001 | 1,001 | — | — | 1,007 | 1,001 | — | — | — | — | — |
| Net cash from financing activities | (665)* | (3) | 1,300* | 0* | 0* | 0 | 0* | 0* | 1,445* | 2,104 | (78)* | (60)* |
Compare with peers
SIC 2844 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.
How peers are chosen
- SIC 2844 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Fewer than three companies fall in that range, so the list adds same-SIC (2844) companies nearest in public float, each marked “added: same SIC”.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| cbdMD | 2,118 | 5,554 | (442)* | 11.2M | 4.8 quarters | 10-QJun 30, 2026 |
| Longevity Health Holdings | 35 | 396 | (224)* | 2.5M | 0.2 quarters | 10-QJun 30, 2026 |
| Caring Brands | 1,820 | not reported | (463)* | 10.4M | 3.9 quarters | 10-QJun 30, 2026 |
| DSwissadded: same SIC | 258 | 512 | 50* | 206.9M | — | 10-QJun 30, 2026 |
| Axil Brandsadded: same SIC | 7,929 | 6,090 | 3,763 | 6.8M | — | 10-QAug 31, 2026 |
| Solesenceadded: same SIC | 1,046 | 15,332 | 191* | 70.6M | — | 10-QJun 30, 2026 |
| Bonkadded: same SIC | 214 | 793 | (2,226)* | 8.0M | 0.1 quarters | 10-QJun 30, 2026 |
| Karbon-Xadded: same SIC | 335 | 344 | (1,198) | 109.2M | — | 10-Q/AAug 31, 2026 |
| United Guardianadded: same SIC | 2,391 | not reported | 1,520* | 4.6M | — | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.
